CNS prophylaxis for diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

CNS prophylaxis for diffuse large B-cell lymphoma

Published:2022-09 Issue:9 Volume:23 Page:e416-e426
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Eyre Toby A,Savage Kerry J,Cheah Chan Y,El-Galaly Tarec C,Lewis Katharine L,McKay Pamela,Wilson Matthew R,Evens Andrew M,Bobillo Sabela,Villa Diego,Maurer Matthew J,Cwynarski Kate,Ferreri Andrés J M

Funder

Manchester Biomedical Research Centre

National Institute for Health and Care Research

Publisher

Elsevier BV

Subject

Oncology

Reference80 articles.

1. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large b-cell lymphoma treated with R-CHOP;Schmitz;J Clin Oncol,2016

2. The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: an international multicenter study of 1532 patients treated with chemoimmunotherapy;El-Galaly;Eur J Cancer,2017

3. Integration of cell of origin into the clinical CNS International Prognostic Index could improve CNS relapse prediction in DLBCL;Klanova;Blood,2019

4. Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial;Gleeson;Ann Oncol,2017

5. Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia;Ong;Leuk Lymphoma,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CNS prophylaxis in large B‐cell lymphomas: A balance with three pans;British Journal of Haematology;2024-09-14

2. Central nervous system prophylaxis in large B‐cell lymphoma: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-08-11

3. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement;BMJ Case Reports;2024-06

4. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma;Leukemia;2024-05-15

5. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma;Blood Advances;2024-03-18